CD274 and non-small cell lung carcinoma: Another study identified circ_0014235 as a factor responsible for conferring Gefitinib resistance and malignant behaviors in non-small cell lung cancer (NSCLC) by governing the miR-146b-5p/YAP/PD-L1 pathway [202].